ABSTRACT

Aim: To study the clinical effectiveness of the proposed complex of therapeutic and preventive measures for oral dysbiosis in patients with removable orthopedic structures.

Methods: We divided 45 patients with removable dentures into 3 groups: those, who received a removable prosthesis "Ftorax"; those, who received a removable prosthesis "Belakryl - EGO" and those, who received the same prosthesis as the second group, but also they used an adhesive dental gel with a probiotic and a synbiotic in the form of a lozenge. In addition, general hygiene measures were recommended for patients of all three groups. Then zones of inflammation were measured and a bacteriological examination of the oral mucosa was carried out.

Results: Two weeks after the start of the study, the inflammatory zone in the second group was significantly smaller compared to the first (410.4 mm² in the upper jaw, 376.1 mm² in the lower jaw and 236.6 mm² in the upper jaw and 200.5 mm² in the lower jaw, respectively). The best results were obtained in the third group (190.5 mm² ,133.3 mm²).

Conclusion: A comparative study of the of the acrylic base polymer "Belacryl-EGO" with the analogue "Ftorax" showed good results in assessing the total area of the inflammatory process of the tissues of the prosthetic bed. The use of the symbiotic and probiotic also led to better results.

MeSH words: Removable dentures, acrylic base plastic, oral dysbiosis, prevention, synbiotics, probiotics